<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="1.2" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJMABHR</journal-id>
<journal-title-group><journal-title>International Journal of Medical and All Body Health Research</journal-title><abbrev-journal-title>IJMABHR</abbrev-journal-title></journal-title-group>
<issn pub-type="epub">2582-8940</issn>
<publisher><publisher-name>Anfo Publication House</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">392</article-id>
<article-id pub-id-type="doi">10.54660/IJMBHR.2025.6.3.260-266</article-id>
<title-group><article-title>Evaluation of Melasma Severity through Serum 8-Hydroxy-2′-Deoxyguanosine Biomarker and MC1R Gene Polymorphisms (rs1805006, rs772551710): A Case–Control Study in Adult Women: A Case-Control Study of Women in Baghdad</article-title></title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Muhsen</surname><given-names>Seham A</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Alwasiti</surname><given-names>Estabraq AR</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Farhood</surname><given-names>Iqbal Ghalib</given-names></name></contrib>
</contrib-group>
<pub-date publication-format="electronic" date-type="pub"><month>07</month><year>2025</year></pub-date>
<volume>6</volume>
<issue>3</issue>
<fpage>260</fpage>
<lpage>266</lpage>
<permissions><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-sa/4.0/?utm"><license-p>CC BY-NC-SA 4.0</license-p></license></permissions>
<self-uri xlink:href="https://www.allmedicaljournal.com/article/392/evaluation-of-melasma-severity-through-serum-8-hydroxy-2-deoxyguanosine-biomarker-and-mc1r-gene"/>
<self-uri content-type="pdf" xlink:href="https://www.allmedicaljournal.com/article/392/download"/>
<abstract><p>Melasma is a chronic hyperpigmentation condition caused by ultraviolet (UV) exposure, light skin pigmentation, and variations in the melanocortin 1 receptor (MC1R) gene. Clinically, it manifests in mandibular, malar, and centrofacial patterns. The study aims to clarify whether elevated levels of 8-hydroxy-2′-deoxyguanosine (8-OHdG) as a biomarker correlate with increased melasma severity and if gene polymorphism (rs1805006 and rs772551710) variations in the MC1R gene influence this relationship. In a case-control study, 120 women from 20 - 50 years 60 took part, melasma and 60 of who had been age-matched healthy controls. Clinical diagnosis was established using Wood&apos;s light examination. Tetra-ARMS PCR was used to determine the MC1R genotypes, and ELISA had been utilized to measure levels of 8-OHdG of the serum. Of statistical analyses were one-way ANOVA, chi-square tests, independent t-tests, odds ratios (OR), and confidence intervals (CI). The Results rs772551710 II genotype (OR=3.28, p=0.002) and rs1805006 CA genotype (OR=4.67, p=0.0004) were significantly associated with melasma. Serum 8-OHdG conc. was markedly increased in patients (3.80 ± 0.22 ng/mL) compared with controls (0.603 ± 0.03 ng/mL, p</p></abstract>
<kwd-group kwd-group-type="author"><kwd>Melasma</kwd><kwd>MC1R Gene Polymorphisms rs1805006</kwd><kwd>rs772551710</kwd><kwd>8-OHdG</kwd><kwd>Electrophoresis</kwd></kwd-group>
</article-meta>
</front>
</article>